Tyrese Haliburton is shocked his Opening Night game is not on national television. That sentence alone tells you everything you need to know about the most medically loaded NBA season in recent memory. The man tore his Achilles in Game 7 of the NBA Finals, missed 16 months, rebuilt his body from the ground up — and he is out here scheduling grievances about broadcast slots. That is a man who is back.
But here is the truth nobody wants to say out loud: not everyone in this comeback class is Tyrese Haliburton. The 2025-26 season was defined by five catastrophic injuries to five star players — an Achilles, two ACLs, another Achilles, another ACL — spanning a nine-month window from April 2025 to January 2026. Now they are all targeting returns to the court in 2026-27. The NBA is about to celebrate a collective resurrection.
Do not buy the narrative wholesale. Returning to the court is not the same as returning to stardom. The medical literature is unambiguous on this. Large-scale studies show ACL returners experience significant performance declines post-injury. Achilles returners face lasting reductions in games played, minutes, and efficiency for at least two seasons post-injury. And every single year of age at injury compounds these outcomes in ways that science is still catching up to.
So let us run the real analysis. Five players. Five injuries. Five very different comeback stories. Here is who is actually coming back — and who is simply suiting up.
The Medical Framework: What the Numbers Actually Say
Before we get into the players, let us establish the baseline. These are the facts the optimistic highlight reels do not include.
On Achilles tears: roughly 72-80% of NBA players return to the court at all. Average return time is 11.23 months. Post-return, players show significant, lasting reductions in games played, minutes per game, and scoring efficiency — not just in the first season back, but across one to two full seasons post-injury. The Orthopaedic Journal of Sports Medicine is not ambiguous about this.
On ACL reconstruction: the return rate is slightly better at 83.6%, with roughly a 12-month average recovery. But a large-scale study of 67 NBA players found that 56 (83.6%) returned to the NBA, with statistically significant declines across the board — PPG from 14.09 to 10.59, and minutes from 28.3 to 22.4. Stanford research offers a counterpoint: players who follow conservative timelines can match uninjured peers. Key word: conservative. Key caveat: that research primarily applies to players averaging 25.7 years of age — not 34, 36, or 37.
Now add the age variable, which is the determinative factor the literature cannot fully capture. At 26, Tyrese Haliburton is near biological peak — regenerative capacity at its ceiling. At 32, Fred VanVleet is manageable, still inside the prime window. At 34, Kyrie Irving is entering medically uncertain territory. At 36, Damian Lillard is standing directly where Kobe Bryant stood when he tore his Achilles and never recovered. At 37, Jimmy Butler is attempting something the medical literature barely has a precedent for at the star level.
Now let us get into it.
Tyrese Haliburton: Comeback Grade — A
The Case for a Full Return
There has never been a more brutal moment to tear an Achilles than the seventh minute of Game 7 of the NBA Finals. Haliburton was mid-play, Indiana was chasing history, and in one non-contact step the season ended for him while the New York Knicks went on to win the championship. That image — Haliburton down on the court, reaching for his heel, Game 7 still going on around him — was the defining visual of the 2025 NBA season.
Sixteen months later, the basketball is straightforward: Haliburton is coming back, and he is coming back right.
The evidence stack is clean. He was playing 5-on-5 by early April 2026 — one of the earliest functional benchmarks for a player on this recovery timeline. He added approximately 30 pounds of muscle during rehab, a deliberate choice to reduce re-injury stress on the repaired tendon. Indiana’s front office was described by ESPN’s Jamal Collier as “extremely optimistic” about Opening Night availability. And Haliburton himself, on his YouTube channel, delivered the best self-scouting quote of the entire offseason:
“I can pretty much say I’m back at this point. I feel like I’m back in shape, but there’s a difference between being in shape and being in Tyrese Haliburton shape.”
That self-awareness is part of why the prognosis is so good. He is not rushing. He is not pretending. He is being precise — which is exactly the personality you want managing a return from the most significant lower-body injury in professional basketball.
There was a shingles diagnosis in February 2026 — stress-induced, likely — that cost him about a month of rehab momentum. It is worth noting and moving past. Shingles does not affect the structural integrity of a recovered Achilles tendon.
The real reason Haliburton is a genuine A-grade comeback is not his age alone. It is what his game actually is. Pre-injury: 18.6 PPG, 9.2 APG, 47.3% FG, ranking second in the NBA in total assists with 325 assists, behind only Trae Young (407 assists). Through 23 playoff games in 2025: 17.3 PPG and 8.6 APG. His game is vision, angles, timing, and shooting — none of which require elite Achilles-driven explosion to execute. Kevin Durant tore his Achilles at 30 and returned to six All-Star seasons and at least five All-NBA selections since his return. Haliburton was 26 at injury, has a less athleticism-dependent game than Durant, and has the most methodical recovery approach of anyone in this class.
Indiana built intelligently around his absence: Ivica Zubac (traded Bennedict Mathurin), Larry Nance Jr., Kelly Oubre Jr., and the highly promising Braden Smith out of Purdue. Pascal Siakam averaged 26.0 points, 7.2 rebounds, and 4.1 assists as the 19-63 Pacers kept some competitive integrity alive. Add Haliburton back into that structure and realistic projections land at 48-50 wins. The East is loaded — Detroit’s 60-22 breakout in 2025-26 is real, LeBron is in Philadelphia, and the Knicks are defending conference champions — but Indiana with a healthy Haliburton is a legitimate fourth-through-sixth seed and a playoff threat.
Projected 2026-27 line: 17-19 PPG | 8.5-9.5 APG | 3.5 RPG
Ceiling: All-Star, All-NBA contender by 2027-28
Fred VanVleet: Comeback Grade — B+
The Most Underrated Return in This Entire Class
Here is what happened in September 2025, weeks before Houston Rockets training camp was set to open: Fred VanVleet flew to a team minicamp in the Bahamas, and his knee, in his words, exploded.
Initial reports said torn ACL. The full picture was worse — torn ACL and torn meniscus, a significantly more complex injury with greater surgical demands, longer rehabilitation requirements, and greater uncertainty around what the knee looks like on the other side. VanVleet had just finished engineering one of the quietly great roster-building stories in recent NBA history: in two seasons, he helped transform Houston from a 22-win lottery team to a 41-win fringe playoff team to a 52-win fifth-seeded Western Conference contender. In the 2025 first-round playoff series against the Warriors, he averaged 13.3 points over seven games as Houston’s alpha playmaker and floor general.
Then his knee exploded in the Bahamas. In September. Before any game had been played.
He opened up about what the next several months looked like on his podcast in summer 2026:
“Missing the playoffs was pretty hard. I remember they told me I could come back in six months. I was feeling good some days. And then Game 1 or 2 and I was like, ‘Damn, I’m going to miss the whole season. I’m not coming back.’ That was a tough time.”
That kind of candor — about the psychological weight of watching from the sideline, the false dawns, the grief of an entire playoff run evaporating — is rare. And it matters, because it tells you VanVleet processed this injury with full emotional honesty rather than performing invincibility. Players who do that tend to come back smarter.
The medical picture at 32 is manageable. The combined ACL and meniscus is legitimately more complex than the other ACL cases in this class, but VanVleet and the Houston medical staff responded with the single most important post-injury decision a player and team can make: they chose a conservative timeline. Surgery came in late September 2025. Return target is Opening Night 2026 — roughly 12-13 months later, which is at the long end of standard ACL recovery but entirely appropriate given the added meniscus work. That is the correct call. Stanford’s research is explicit: conservative timelines allow returners to match uninjured peers. Rushing is how you become a cautionary tale.
VanVleet exercised his $25 million player option for 2026-27 rather than testing unrestricted free agency — a statement of confidence in his own recovery. His game, critically, is built on the things that survive major injuries: volume three-point shooting (neurological and mechanical), anticipation-based defending (scheme and IQ), and low-turnover playmaking (basketball intellect, not athleticism). He averaged 6.9 assists per game and only 1.6 turnovers per 36 minutes in Houston — a ratio that does not come from explosiveness. It comes from reading the game, and that does not get surgically removed.
The team context is exceptional. Kevin Durant has played one full season in Houston without a true lead point guard. The pick-and-roll partnership between VanVleet and Durant is one of the most promising two-man actions in the entire Western Conference if VanVleet returns anywhere close to form. Alperen Sengun is a rising star. Amen Thompson is a two-way force. Reed Sheppard made significant developmental leaps during VanVleet’s absence. Marcus Smart was signed to anchor the bench defense. ESPN called Houston a “flawed West contender” — but that framing is explicitly predicated on VanVleet’s absence. Add him back and the calculus shifts dramatically.
There is also the contract-year pressure. The Athletic’s Kevin O’Connor noted that Houston’s failure to negotiate a longer, lower-rate extension carries an implicit message: perform this year, or the Rockets restructure around Thompson and Sheppard. VanVleet himself told anyone who would listen that Houston “can win a championship next year.” He is not playing for survival here. He is playing for legacy.
Coach Ime Udoka confirmed on September 11, 2026 that VanVleet was “ramping up his rehab work” with Opening Night in his sights. This is the most underestimated comeback in the entire class.
Projected 2026-27 line: 14-17 PPG | 6-7 APG | 3.5 RPG | 1.5 SPG
Ceiling: All-Star conversation, Houston West contention
Kyrie Irving: Comeback Grade — B
The Body Is Ready. Everything Else Is Complicated.
Let us deal with the medical reality first, because it is actually the good news here. On the Stephen A. Smith Show in summer 2026, Shams Charania said this about Irving: “He’s fully recovered, 100% from that ACL tear. He’s been fully entrenched with the Mavericks’ plans this offseason.” Footage from NBPA Top 100 Camp showed Irving’s signature handle and footwork completely intact — which tracks, because Irving’s offensive genius is not speed-dependent. It is neurological and mechanical. His handle, his angles, his footwork, his separation creation — these are skills burned into muscle memory across two decades, not expressions of raw athletic explosion. The Stanford research about conservative timelines applies here. Irving at 34 is not the same risk profile as Lillard at 36 or Butler at 37.
Pre-injury in 2024-25, Irving was averaging 24.7 PPG, 4.6 APG on 47.3/40.1/91.6 shooting splits — elite efficiency for anyone, genuinely remarkable for a mid-30s guard. The career resume is not in question. Twelve All-Star selections. A career 16.8 PPG average. The handle is still there. The shooting is still there.
Now for the complicated part.
Dallas went 26-56 without Irving and without Luka Doncic (who was traded to the Lakers, with Anthony Davis coming to Dallas in the deal that has already produced more discourse than any trade in recent NBA history). The rebuilding project now centers on Cooper Flagg — a 19-year-old franchise cornerstone who arrived and immediately justified every superlative thrown at him. There is approximately a 14-year age gap between Flagg and Irving. That is not inherently disqualifying; veteran-rookie pairings have worked throughout NBA history. But it requires a specific kind of veteran buy-in, and Irving’s history of buy-in is, charitably, complicated.
Oddsmakers have Dallas win totals sitting at 32.5-34.5 — better than their disaster year, not a playoff lock. The roster additions were competent but not transformative: Santi Aldama, Marcus Sasser, Zaccharie Risacher. Irving carries approximately $39.5 million for 2026-27 with a player option for 2027-28, which gives him leverage but also makes him a significant financial reality in a building-around-youth situation.
Here is the trade deadline shadow hanging over this entire story: if Dallas starts somewhere in the 15-25 range before January, the noise around moving Irving’s expiring deal will become deafening. Rival executives are already having those conversations. The roster is not built to compete in the West where Oklahoma City, San Antonio, and Houston have established themselves as the conference crown. There is a version of this season where Irving, fully healthy, is nevertheless performing for a trade audience by February.
The comeback itself is real. The 20-plus PPG scorer version of Kyrie Irving absolutely still exists. The B grade is not about his body — it is about his situation, his trajectory, and the legitimate question of whether adapting from a primary on-ball star to a more off-ball contributor alongside a teenager is something Irving has ever shown the interest or flexibility to do.
Projected 2026-27 line: 20-23 PPG | 5-6 APG | 4-5 RPG
Wildcard: trade deadline, role definition, availability history
Damian Lillard: Comeback Grade — C+
The Three-Point Contest Was Beautiful. The Medical Reality Is Brutal.
Let us start with the most emotionally resonant moment of the entire 2025-26 NBA season: Damian Lillard winning the Three-Point Contest at All-Star Weekend while still months away from returning to actual basketball. He made over 100,000 shots during rehabilitation. He showed up to the contest, which is essentially a sport-specific cardiovascular and mechanical test with a crowd watching, and won it. That shot-making touch — the thing that made him one of the most feared offensive players of his generation — survived intact.
The basketball world watched and exhaled. Dame is back.
But here is what the Three-Point Contest does not tell you: it does not test first-step explosion off the dribble. It does not require the Achilles-driven push into a step-back. It does not require lateral cuts, direction changes, or the kind of initial burst that separates elite isolation scorers from good ones. Lillard’s game — at his peak, averaging 24.9 PPG, 7.1 APG, 4.7 RPG in his last healthy Milwaukee season — was built significantly on pull-up threes off screens, step-backs, and isolation creation. Those require the exact biomechanics that an Achilles tear most directly compromises.
The age math here is the most sobering in the class. Lillard was 36 at the time of his Achilles tear. Kobe Bryant tore his Achilles at 34 — one year younger — rushed back in eight months, suffered additional leg injuries across the following seasons, and was never again a franchise centerpiece. Kevin Durant tore his at 30 — six years younger than Lillard — took an 18-month recovery, and returned to six All-Star appearances. Dominique Wilkins ruptured his Achilles tendon midway through the 1991-92 season at age 32 and averaged 29.9 PPG the following year, which sounds optimistic until you account for the four-year gap from Lillard’s current age and the fact that Wilkins’ game was above-the-rim athleticism at its biological peak — the opposite profile from a 36-year-old guard who has been out 17-plus months.
The timeline alone raises flags. As of September 9, 2026 — with the season weeks away — Lillard was only described as “preparing to return to the court for the first time.” He is the most cautious physical timeline in the entire comeback class by a significant margin. That caution is medically appropriate; the research consistently shows that second-season Achilles re-tears are most dangerous in the 18-24 month window post-injury. But appropriate caution still means Lillard is not striding into the 2026-27 season ready to be a top-ten offensive player.
The Portland context adds another layer. The Trail Blazers made the playoffs in 2025-26 for the first time since 2021, built around Deni Avdija’s All-Star breakout and a genuine defensive identity. They then acquired Ja Morant from Memphis — a legitimate superstar when healthy, but someone who has averaged 79 games across three recent seasons and carries off-court history — for Jerami Grant and Kris Murray, which is objectively a low price. The projected starting backcourt of Lillard and Morant features two dominant ball-handlers, two injury-prone stars, and precisely zero natural fit on paper.
Coach Brian Shaw did not pretend otherwise: “Eventually, at least one of the Blazers’ prominent guards will be asked to make uncomfortable sacrifices.”
Lillard signed a three-year, $42 million deal with Portland — a dramatic discount from any realistic All-Star market valuation — because he wanted to go home and be near his three children. That is the most human decision in this entire story and deserves genuine respect. It is also a decision that prioritized proximity and meaning over optimal basketball situation.
The best-case Lillard in 2026-27 looks like a veteran assassin: deadly off the catch, lethal from the pull-up range when the step-back is working, orchestrating from the top of the key while Morant and Avdija shoulder the primary creation burden. That is a real and valuable player. It is not a top-ten player. It is not an All-NBA discussion. That conversation belongs to 2027-28 at the earliest, if he stays healthy and the Achilles responds well to full competitive stress.
The shooting touch is real. The heart is unquestionable. The medical math at 36, 17-plus months removed from an Achilles tear, is unforgiving.
Projected 2026-27 line: 18-21 PPG | 5.5-6.5 APG | 3.5 RPG
Ceiling: Meaningful contributor; full-star return belongs to 2027-28
Jimmy Butler: Comeback Grade — D+
The Most Medically Precarious Situation in Modern NBA History
Jimmy Butler at Golden State was genuinely working. In 38 games before January 19, 2026, he averaged 20.0 PPG, 5.6 RPG, 4.9 APG, and 1.5 steals — the connective tissue a Stephen Curry co-star needs, the two-way threat that makes the Warriors dangerous rather than just old. He said it himself in June 2026: “It’s not good, it’s great. Legitimately, it’s the best.”
Then came the awkward landing against Miami. The right knee buckled. Surgery followed on February 9, 2026.
Standard ACL reconstruction recovery is nine to twelve months post-surgery. Nine months from February 9 is November 2026. Twelve months is February 2027. As of August 24, 2026, reporting from NBA.com and RotoWire described Butler as “still in the relatively early stages of his recovery” and having “only recently begun getting back on the court.” In June, he told The Athletic’s Nick Friedell he was approximately “a month and a half away from running again.” Running. Not cutting. Not dunking off his right leg. Running.
A December 2026 return was being described as optimistic. January to February 2027 as the more realistic target. As training camp opened in September 2026, Butler was not cleared for full contact work.
Here is the number that contextualizes all of this: the large-scale ACL research involves players averaging 25.7 years of age. Jimmy Butler is 37. There is no meaningful historical NBA comparison for a star-level player returning from a torn ACL at 37. The players who have tried it at this age were role players, not franchise-level contributors. Most stars in this situation retire. The science barely applies because science has barely encountered this before.
What gives Butler a fighting chance — and this is worth saying clearly, because his competitive character is not in question — is that his game has never been built on youth. He draws fouls at a career rate through IQ and physicality, not first-step quickness. He makes difficult mid-range shots through footwork and shot creation mechanics, not athleticism. He creates defensive chaos through positioning and instinct, not explosion. These skills age better than most. Butler at 80% of his peak self is still a problem for most NBA opponents.
But 80% at 37, coming off an ACL tear, playing his first games in January or February? That is a very specific and limited product. The Golden State financial picture around him is simultaneously impressive and suffocating: Curry at $62.6 million, Butler at $56.8 million, Draymond Green at $27.7 million, Kristaps Porzingis at $20.0 million. That is an enormous commitment to age and injury risk. The Warriors went 37-45 the rest of the 2025-26 season with Butler and Curry both missing significant time, lost in the Play-In to Phoenix, and watched the Western Conference crown get claimed by Oklahoma City, San Antonio, and Houston.
The Warriors medical team under Rick Celebrini is known for caution and sophistication. The fact that Butler was still in early-stage recovery in late August — seven months post-surgery — tells you they are not gambling on timeline. Every game Butler plays at a high level is a commercial for his value and a case for the Warriors’ championship window remaining open. Every missed game is trade deadline fuel. His $56.8 million contract is the final guaranteed year, making 2026-27 a de facto last-chance audition for whatever comes next.
Best case: Butler returns in December or January, plays 35-45 genuinely excellent games, Golden State makes a playoff run and revives the optimism. Worst case: he returns in February or March, plays 20 games at clearly diminished production, and what was one of the league’s most compelling storylines becomes a poignant retirement season by another name. Most likely outcome falls somewhere in the middle — 25-40 games of real effectiveness, insufficient to make the Warriors a genuine title threat against a Western Conference that has moved on without them.
Projected 2026-27 line (when available): 17-19 PPG | 5 RPG | 4 APG
Reality: Season in genuine doubt; window may be closed regardless of what the scoreline says
The Skills vs. Athleticism Dividing Line
Step back from the individual cases for a second and the single most predictive factor in all five comebacks becomes clear: what does each player’s game actually require from their body?
Haliburton and VanVleet are pure IQ players. Their production comes from reading the game, shooting mechanics developed over thousands of reps, and a cognitive processing speed that no surgery can remove. Their Achilles and ACL health matters for durability, but the quality of their production is largely preserved.
Irving’s signature is neurological and mechanical — the handle, the footwork, the angle creation. These are embedded at a level deeper than athleticism. His floor is unusually high for a 34-year-old ACL returner precisely because his ceiling was never about speed. It was about craft.
Lillard is a hybrid, and that is his medical problem. The pull-up three off the dribble, the step-back, the isolation creation — these require genuine Achilles-powered explosiveness to create the initial separation. The shooting touch survives. The creation engine is the question. At 36, after 17-plus months away, asking that engine to perform at pre-injury levels is asking a lot.
Butler’s game, ironically, is the most age-proof of the five. Foul generation through IQ and physicality. Mid-range creation through footwork. Defensive disruption through position and instinct. If he is on the court, he is dangerous. The entire problem is getting him on the court, and at 37, after a February ACL surgery, that is not a given.
The Human Thread Running Through All of It
The basketball analysis matters. The grades matter. But so does this: these are five men who had their careers interrupted by the worst possible kinds of injuries at the worst possible times, and every single one of them chose to come back.
Lillard did not chase a contender after the Bucks waived him. He went home to Portland to be near his kids, signed for a fraction of his market value, and made 100,000 shots in a gym while his knee healed. VanVleet sat alone watching Houston’s playoff run from a seat that should have been his and was honest enough to admit it almost broke him. Haliburton, down on the court in Game 7 of the NBA Finals while the championship continued around him, rebuilt himself over 16 months and came back outraged that his return game is not on national television — which is genuinely the most Haliburton possible response. Irving showed up to the NBPA Top 100 Camp in summer 2026 and dazzled a gym full of teenagers, not because he had anything to prove, but because basketball is still what he loves. And Butler, seven months post-surgery, not yet running at full speed, still insisted that Golden State is “the best.”
The basketball is riveting. The human stories are transcendent.
The Final Grades
Here is the straight ranking, most to least likely to return to genuine star-level production in 2026-27:
- Tyrese Haliburton — Grade: A. Full comeback. Opening Night. All-Star ceiling intact. The clearest return story in the class.
- Fred VanVleet — Grade: B+. The most underrated member of the class. Solid comeback, conservative approach, perfect team fit, championship-level motivation. Do not sleep on this one.
- Kyrie Irving — Grade: B. The body is there. The situation is complicated. The talent is undeniable and the team context around him is a powder keg.
- Damian Lillard — Grade: C+. Meaningful contributor but realistically diminished. The shooting touch survived. The creation engine is the question. All-NBA conversation belongs to another year.
- Jimmy Butler — Grade: D+. The most medically precarious comeback in the group. Window may already be closed. If he plays 40 excellent games and the Warriors make noise, revise upward. But the base case is a season in genuine doubt.
The 2026-27 NBA season is going to answer questions that medical literature, historical comparisons, and age projections can only approximate. Somewhere between the triumphant return and the sobering new reality, five of basketball’s best players are going to find out exactly what they have left. The answer will not be the same for all five — and that, honestly, is what makes this the most fascinating collection of storylines the league has seen in years.
Tyrese Haliburton is right to be outraged about the broadcast schedule. The opening night of his comeback should be on every screen in the country. Whether the same can be said for every member of this class by February is a different question entirely.